Evidence map›Paper›PMID 34341670›Full record

ReviewDiagnostic histopathology (Oxford, England)2021

Use of post-mortem computed tomography during the COVID-19 pandemic.

Ian Sd Roberts, Zoe C Traill

Abstract readReview
In one paragraph

Review in Diagnostic histopathology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Critical care and pandemic preparedness and response.British journal of anaesthesia · 2023
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ian Sd RobertsProfessor of Cellular Pathology, The University of Oxford, UK and Consultant Pathologist, Oxford University Hospitals NHS Foundation Trust, UK. Conflicts of interest: Director, Oramis Digital Autopsy Limited; Consultant for iGene, providing Digital Autopsy training for radiologists and pathologists.
Zoe C TraillProfessor of Cellular Pathology, The University of Oxford, UK and Consultant Pathologist, Oxford University Hospitals NHS Foundation Trust, UK. Conflicts of interest: Director, Oramis Digital Autopsy Limited; Consultant for iGene, providing Digital Autopsy training for radiologists and pathologists.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post mortem computed tomography (PMCT) is widely used in England and Wales to supplement or replace traditional invasive Coroner's autopsy. Using PMCT and coronary angiography, the cause of death can be determined without invasive examination in approximately 70% of cases, assuming a typical Coroner's autopsy case mix. Coroner's autopsy services continued during the COVID-19 pandemic and have identified deaths resulting from COVID-19 undiagnosed in life. In some areas of England, PMCT was used to replace traditional autopsy due to concerns over infection risk to mortuary staff associated with invasive autopsy. Health and safety concerns also resulted in changes to post mortem scanning protocols. PMCT has been used to identify potential COVID-19 deaths and assist in the selection of cases for viral studies. There is typically bilateral ground-glass opacities and consolidation within the lungs on CT; although these changes are not specific for COVID-19, the diagnosis can be confirmed with post mortem nose and throat swabs.

Indexed as

coroner's autopsyCOVID-19digital autopsypost mortem CT

Identifiers

PMID34341670
PMCPMC8318681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.